NIH-funded research R01 grant

Understanding how a brain signaling pathway affects the body's internal clock

Official title: Mammalian target of rapamycin signaling and the suprachiamatic circadian clock

Funded at Rutgers Biomedical and Health Sciences · NIH-10878903 · Data updated 2026-11-12

This study is exploring how a specific pathway in the brain helps control our body's internal clock, which affects our sleep and daily rhythms, and it's designed for anyone interested in understanding how our bodies stay in sync with day and night.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 20, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$357,882
NIH project number5R01NS118026-06
Project IDNIH-10878903 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing circadian rhythm disruptions, such as those with sleep disorders or mood disorders linked to circadian dysregulation.

Less likely to help

Patients with stable circadian rhythms or those not experiencing any sleep-related issues may not benefit from this research.

What this research studies

This research investigates the role of the mammalian target of rapamycin (mTOR) signaling pathway in regulating the circadian clock located in the brain's suprachiasmatic nucleus (SCN). By manipulating specific components of the mTOR pathway through genetic and pharmacological methods, the study aims to uncover how these signals influence gene expression and protein synthesis that synchronize the body's internal clock with external environmental cues. The research employs a multidisciplinary approach, assessing molecular, cellular, and behavioral aspects of circadian function in animal models.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for circadian rhythm disorders, improving sleep quality and overall health.

How similar studies have gone: Previous research has shown promising results in understanding the mTOR pathway's role in various biological processes, suggesting that this approach may yield valuable insights into circadian regulation.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Cao, Ruifeng (Ray) — Rutgers Biomedical and Health Sciences
  • Study coordinator: Cao, Ruifeng (Ray)

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.